Literature DB >> 32672965

Structural Analysis of Potent Hybrid HIV-1 Protease Inhibitors Containing Bis-tetrahydrofuran in a Pseudosymmetric Dipeptide Isostere.

Linah N Rusere1, Gordon J Lockbaum1, Mina Henes1, Sook-Kyung Lee2, Ean Spielvogel2, Desaboini Nageswara Rao1, Klajdi Kosovrasti1, Ellen A Nalivaika1, Ronald Swanstrom2, Nese Kurt Yilmaz1, Celia A Schiffer1, Akbar Ali1.   

Abstract

The design, synthesis, and X-ray structural analysis of hybrid HIV-1 protease inhibitors (PIs) containing bis-tetrahydrofuran (bis-THF) in a pseudo-C2-symmetric dipeptide isostere are described. A series of PIs were synthesized by incorporating bis-THF of darunavir on either side of the Phe-Phe isostere of lopinavir in combination with hydrophobic amino acids on the opposite P2/P2' position. Structure-activity relationship studies indicated that the bis-THF moiety can be attached at either the P2 or P2' position without significantly affecting potency. However, the group on the opposite P2/P2' position had a dramatic effect on potency depending on the size and shape of the side chain. Cocrystal structures of inhibitors with wild-type HIV-1 protease revealed that the bis-THF moiety retained similar interactions as observed in the darunavir-protease complex regardless of the position on the Phe-Phe isostere. Analyses of cocrystal structures and molecular dynamics simulations provide insights into optimizing HIV-1 PIs containing bis-THF in non-sulfonamide dipeptide isosteres.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32672965      PMCID: PMC7971191          DOI: 10.1021/acs.jmedchem.0c00529

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  51 in total

1.  Free R value: a novel statistical quantity for assessing the accuracy of crystal structures.

Authors:  A T Brünger
Journal:  Nature       Date:  1992-01-30       Impact factor: 49.962

2.  Structural basis and distal effects of Gag substrate coevolution in drug resistance to HIV-1 protease.

Authors:  Ayşegül Özen; Kuan-Hung Lin; Nese Kurt Yilmaz; Celia A Schiffer
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-29       Impact factor: 11.205

3.  Processing of X-ray diffraction data collected in oscillation mode.

Authors:  Z Otwinowski; W Minor
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

4.  Dynamics of preferential substrate recognition in HIV-1 protease: redefining the substrate envelope.

Authors:  Ayşegül Ozen; Türkan Haliloğlu; Celia A Schiffer
Journal:  J Mol Biol       Date:  2011-07-22       Impact factor: 5.469

5.  Synthesis and SAR studies of potent HIV protease inhibitors containing novel dimethylphenoxyl acetates as P2 ligands.

Authors:  Xiaoqi Chen; Dale J Kempf; Lin Li; Hing L Sham; Sudthida Vasavanonda; Norman E Wideburg; Ayda Saldivar; Kennan C Marsh; Edith McDonald; Daniel W Norbeck
Journal:  Bioorg Med Chem Lett       Date:  2003-11-03       Impact factor: 2.823

6.  Long-Range Electrostatics-Induced Two-Proton Transfer Captured by Neutron Crystallography in an Enzyme Catalytic Site.

Authors:  Oksana Gerlits; Troy Wymore; Amit Das; Chen-Hsiang Shen; Jerry M Parks; Jeremy C Smith; Kevin L Weiss; David A Keen; Matthew P Blakeley; John M Louis; Paul Langan; Irene T Weber; Andrey Kovalevsky
Journal:  Angew Chem Int Ed Engl       Date:  2016-03-09       Impact factor: 15.336

7.  Design and synthesis of HIV-1 protease inhibitors for a long-acting injectable drug application.

Authors:  Bart Kesteleyn; Katie Amssoms; Wim Schepens; Geerwin Hache; Wim Verschueren; Wim Van De Vreken; Klara Rombauts; Greet Meurs; Patrick Sterkens; Bart Stoops; Lieven Baert; Nigel Austin; Jörg Wegner; Chantal Masungi; Inge Dierynck; Stina Lundgren; Daniel Jönsson; Kevin Parkes; Genadiy Kalayanov; Hans Wallberg; Asa Rosenquist; Bertil Samuelsson; Kristof Van Emelen; Jan Willem Thuring
Journal:  Bioorg Med Chem Lett       Date:  2012-11-01       Impact factor: 2.823

8.  Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society-USA Panel.

Authors:  Michael S Saag; Constance A Benson; Rajesh T Gandhi; Jennifer F Hoy; Raphael J Landovitz; Michael J Mugavero; Paul E Sax; Davey M Smith; Melanie A Thompson; Susan P Buchbinder; Carlos Del Rio; Joseph J Eron; Gerd Fätkenheuer; Huldrych F Günthard; Jean-Michel Molina; Donna M Jacobsen; Paul A Volberding
Journal:  JAMA       Date:  2018-07-24       Impact factor: 56.272

9.  Regulation of autoproteolysis of the HIV-1 and HIV-2 proteases with engineered amino acid substitutions.

Authors:  J R Rosé; R Salto; C S Craik
Journal:  J Biol Chem       Date:  1993-06-05       Impact factor: 5.157

10.  A novel central nervous system-penetrating protease inhibitor overcomes human immunodeficiency virus 1 resistance with unprecedented aM to pM potency.

Authors:  Manabu Aoki; Hironori Hayashi; Kalapala Venkateswara Rao; Debananda Das; Nobuyo Higashi-Kuwata; Haydar Bulut; Hiromi Aoki-Ogata; Yuki Takamatsu; Ravikiran S Yedidi; David A Davis; Shin-Ichiro Hattori; Noriko Nishida; Kazuya Hasegawa; Nobutoki Takamune; Prasanth R Nyalapatla; Heather L Osswald; Hirofumi Jono; Hideyuki Saito; Robert Yarchoan; Shogo Misumi; Arun K Ghosh; Hiroaki Mitsuya
Journal:  Elife       Date:  2017-10-17       Impact factor: 8.140

View more
  1 in total

1.  Viral proteases: Structure, mechanism and inhibition.

Authors:  Jacqueto Zephyr; Nese Kurt Yilmaz; Celia A Schiffer
Journal:  Enzymes       Date:  2021-11-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.